Response to Letters regarding "Risk and Benefit of mRNA COVID-19 Vaccines for the Omicron Variant by Age, Sex, and Presence of Comorbidity: A Quality-Adjusted Life Years Analysis"

Am J Epidemiol. 2023 Dec 19:kwad243. doi: 10.1093/aje/kwad243. Online ahead of print.
No abstract available

Keywords: COVID-19; quality-adjusted life years; risk; safety; vaccine.